These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17352478)

  • 1. Role of aspartate-1 in Cu(II) binding to the amyloid-beta peptide of Alzheimer's disease.
    Karr JW; Szalai VA
    J Am Chem Soc; 2007 Apr; 129(13):3796-7. PubMed ID: 17352478
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of isomerization of aspartate-7 on the binding of copper (II) ion by the beta-amyloid peptide].
    Tsvetkov FO; Makarov AA; Archakov AI; Kozin SA
    Biofizika; 2009; 54(2):197-201. PubMed ID: 19402527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cu(II) binding to monomeric, oligomeric, and fibrillar forms of the Alzheimer's disease amyloid-beta peptide.
    Karr JW; Szalai VA
    Biochemistry; 2008 Apr; 47(17):5006-16. PubMed ID: 18393444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A direct determination of the dissociation constant for the Cu(II) complex of amyloid beta 1-40 peptide.
    Rózga M; Kłoniecki M; Dadlez M; Bal W
    Chem Res Toxicol; 2010 Feb; 23(2):336-40. PubMed ID: 19911803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-beta binds Cu2+ in a mononuclear metal ion binding site.
    Karr JW; Kaupp LJ; Szalai VA
    J Am Chem Soc; 2004 Oct; 126(41):13534-8. PubMed ID: 15479110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct evidence that all three histidine residues coordinate to Cu(II) in amyloid-beta1-16.
    Shin BK; Saxena S
    Biochemistry; 2008 Sep; 47(35):9117-23. PubMed ID: 18690709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The second Cu(II)-binding site in a proton-rich environment interferes with the aggregation of amyloid-beta(1-40) into amyloid fibrils.
    Jun S; Gillespie JR; Shin BK; Saxena S
    Biochemistry; 2009 Nov; 48(45):10724-32. PubMed ID: 19824649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isomerization of the Asp7 residue results in zinc-induced oligomerization of Alzheimer's disease amyloid beta(1-16) peptide.
    Tsvetkov PO; Popov IA; Nikolaev EN; Archakov AI; Makarov AA; Kozin SA
    Chembiochem; 2008 Jul; 9(10):1564-7. PubMed ID: 18506864
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of copper binding to the peptide amyloid-beta(1-16) associated with Alzheimer's disease.
    Ma QF; Hu J; Wu WH; Liu HD; Du JT; Fu Y; Wu YW; Lei P; Zhao YF; Li YM
    Biopolymers; 2006 Sep; 83(1):20-31. PubMed ID: 16615111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic studies of Cu(II) binding to amyloid-beta peptides and the fluorescence and redox behaviors of the resulting complexes.
    Maiti NC; Jiang D; Wain AJ; Patel S; Dinh KL; Zhou F
    J Phys Chem B; 2008 Jul; 112(28):8406-11. PubMed ID: 18570397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
    Tõugu V; Karafin A; Palumaa P
    J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modeling of zinc and copper binding with Alzheimer's amyloid beta-peptide.
    Han D; Wang H; Yang P
    Biometals; 2008 Apr; 21(2):189-96. PubMed ID: 17629774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide.
    Danielsson J; Pierattelli R; Banci L; Gräslund A
    FEBS J; 2007 Jan; 274(1):46-59. PubMed ID: 17222176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cu(II) complex of Abeta40 peptide in ammonium acetate solutions. Evidence for ternary species formation.
    Rózga M; Protas AM; Jabłonowska A; Dadlez M; Bal W
    Chem Commun (Camb); 2009 Mar; (11):1374-6. PubMed ID: 19259592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of copper(II) inhibiting Alzheimer's amyloid beta-peptide from aggregation: a molecular dynamics investigation.
    Jiao Y; Yang P
    J Phys Chem B; 2007 Jul; 111(26):7646-55. PubMed ID: 17564430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease related copper(II)- beta-amyloid peptide exhibits phenol monooxygenase and catechol oxidase activities.
    da Silva GF; Ming LJ
    Angew Chem Int Ed Engl; 2005 Aug; 44(34):5501-4. PubMed ID: 16052638
    [No Abstract]   [Full Text] [Related]  

  • 17. Substrate mediated reduction of copper-amyloid-beta complex in Alzheimer's disease.
    Streltsov VA; Varghese JN
    Chem Commun (Camb); 2008 Jul; (27):3169-71. PubMed ID: 18594731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metal loading ability of beta-amyloid N-terminus: a combined potentiometric and spectroscopic study of copper(II) complexes with beta-amyloid(1-16), its short or mutated peptide fragments, and its polyethylene glycol (PEG)-ylated analogue.
    Damante CA; Osz K; Nagy Z; Pappalardo G; Grasso G; Impellizzeri G; Rizzarelli E; Sóvágó I
    Inorg Chem; 2008 Oct; 47(20):9669-83. PubMed ID: 18808108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrochemical and conformational consequences of copper (Cu(I) and Cu(II)) binding to beta-amyloid(1-40).
    Brzyska M; Trzesniewska K; Wieckowska A; Szczepankiewicz A; Elbaum D
    Chembiochem; 2009 Apr; 10(6):1045-55. PubMed ID: 19263448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR.
    Ma QF; Li YM; Du JT; Kanazawa K; Nemoto T; Nakanishi H; Zhao YF
    Biopolymers; 2005 Oct; 79(2):74-85. PubMed ID: 15986501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.